Tonix Pharmaceuticals Holding Corp. (TNXP) stock
TNXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 10/3083% below fair value
$2.94+0.06 (+2.08%)
Close on Nov 17, 2026Market cap $50.42MP/E –Yield –
Tonix Pharmaceuticals cash
Cash and short-term investments held at the end of each period.
Tonix Pharmaceuticals's cash was $176.23M at Jun 30, 2026. For fiscal 2025 it was $207.64M, up 108.3% from the year before. Over ten years it grew 19.6% a year on average. The highest annual figure on record is $207.64M in fiscal 2025.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $207.64M | +108.3% |
| FY2024 | Dec 31, 2024 | $99.68M | +285.6% |
| FY2023 | Dec 31, 2023 | $25.85M | -78.5% |
| FY2022 | Dec 31, 2022 | $120.47M | -32.7% |
| FY2021 | Dec 31, 2021 | $178.90M | +131.4% |
| FY2020 | Dec 31, 2020 | $77.31M | +581.2% |
| FY2019 | Dec 31, 2019 | $11.35M | -54.8% |
| FY2018 | Dec 31, 2018 | $25.13M | -1.8% |
| FY2017 | Dec 31, 2017 | $25.59M | +34.4% |
| FY2016 | Dec 31, 2016 | $19.03M | -45.1% |
| FY2015 | Dec 31, 2015 | $34.69M | -9.1% |
| FY2014 | Dec 31, 2014 | $38.18M | +365.5% |
| FY2013 | Dec 31, 2013 | $8.20M | +359.5% |
| FY2012 | Dec 31, 2012 | $1.79M | +4253.7% |
| FY2011 | Dec 31, 2011 | $41.00K | -37.3% |
| FY2010 | Dec 31, 2010 | $65.36K | +6037.0% |
| FY2009 | Dec 31, 2009 | $1.07K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $176.23M | +39.6% |
| Q1 FY2026 | Mar 31, 2026 | $185.47M | +40.8% |
| Q4 FY2025 | Dec 31, 2025 | $207.64M | +108.3% |
| Q3 FY2025 | Sep 30, 2025 | $190.06M | +573.2% |
| Q2 FY2025 | Jun 30, 2025 | $126.24M | +2937.4% |
| Q1 FY2025 | Mar 31, 2025 | $131.72M | +1768.6% |
| Q4 FY2024 | Dec 31, 2024 | $99.68M | +285.6% |
| Q3 FY2024 | Sep 30, 2024 | $28.23M | +308.3% |
| Q2 FY2024 | Jun 30, 2024 | $4.16M | -83.8% |
| Q1 FY2024 | Mar 31, 2024 | $7.05M | -90.2% |
| Q4 FY2023 | Dec 31, 2023 | $25.85M | -78.5% |
| Q3 FY2023 | Sep 30, 2023 | $6.91M | -95.1% |
| Q2 FY2023 | Jun 30, 2023 | $25.62M | -82.4% |
| Q1 FY2023 | Mar 31, 2023 | $71.98M | -48.7% |
| Q4 FY2022 | Dec 31, 2022 | $120.47M | -32.7% |
| Q3 FY2022 | Sep 30, 2022 | $139.98M | -23.5% |
| Q2 FY2022 | Jun 30, 2022 | $145.48M | -12.2% |
| Q1 FY2022 | Mar 31, 2022 | $140.44M | -14.5% |
| Q4 FY2021 | Dec 31, 2021 | $178.90M | +131.4% |
| Q3 FY2021 | Sep 30, 2021 | $182.97M | +227.3% |
| Q2 FY2021 | Jun 30, 2021 | $165.72M | +200.6% |
| Q1 FY2021 | Mar 31, 2021 | $164.21M | +433.8% |
| Q4 FY2020 | Dec 31, 2020 | $77.31M | +581.2% |
| Q3 FY2020 | Sep 30, 2020 | $55.90M | +452.1% |
| Q2 FY2020 | Jun 30, 2020 | $55.12M | +350.0% |
| Q1 FY2020 | Mar 31, 2020 | $30.77M | +85.9% |
| Q4 FY2019 | Dec 31, 2019 | $11.35M | -54.8% |
| Q3 FY2019 | Sep 30, 2019 | $10.12M | -31.5% |
| Q2 FY2019 | Jun 30, 2019 | $12.25M | -26.9% |
| Q1 FY2019 | Mar 31, 2019 | $16.55M | -14.4% |
| Q4 FY2018 | Dec 31, 2018 | $25.13M | -1.8% |
| Q3 FY2018 | Sep 30, 2018 | $14.77M | -49.7% |
| Q2 FY2018 | Jun 30, 2018 | $16.77M | -51.3% |
| Q1 FY2018 | Mar 31, 2018 | $19.34M | -3.4% |
| Q4 FY2017 | Dec 31, 2017 | $25.59M | +34.4% |
| Q3 FY2017 | Sep 30, 2017 | $29.40M | +87.9% |
| Q2 FY2017 | Jun 30, 2017 | $34.44M | – |
| Q1 FY2017 | Mar 31, 2017 | $20.03M | – |
| Q4 FY2016 | Dec 31, 2016 | $19.03M | – |
| Q3 FY2016 | Sep 30, 2016 | $15.64M | – |
See a number that looks wrong?